Cerity Partners’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1M Buy
10,379
+4,289
+70% +$440K ﹤0.01% 1861
2025
Q4
$646K Sell
6,090
-7,895
-56% -$915K ﹤0.01% 1949
2025
Q3
$1.78M Sell
13,985
-37,311
-73% -$4.44M ﹤0.01% 1347
2025
Q2
$6.29M Buy
51,296
+46,569
+985% +$5.32M 0.01% 709
2025
Q1
$479K Sell
4,727
-1,110
-19% -$108K ﹤0.01% 1776
2024
Q4
$547K Buy
5,837
+2,537
+77% +$249K ﹤0.01% 1711
2024
Q3
$319K Buy
+3,300
New +$297K ﹤0.01% 2011
2024
Q1
Sell
-29,433
Closed -$1.96M 2298
2023
Q4
$1.96M Sell
29,433
-944
-3% -$61.1K 0.01% 779
2023
Q3
$2.04M Sell
30,377
-498
-2% -$34.3K 0.01% 583
2023
Q2
$2.09M Buy
+30,875
New +$1.93M 0.01% 720

Other funds holding EHC

Cerity Partners's EHC Position: Q1 2026 in Review

Cerity Partners increased its Encompass Health (EHC) stake by 70% in Q1 2026, buying an estimated $440K and bringing the position to 10,379 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #1861.

Cerity Partners first reported a position in EHC in Q2 2023 and has held it in 10 quarters since. The position peaked at $6.29M in Q2 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Cerity Partners held 10,379 shares of Encompass Health worth $1M as of Q1 2026.
  • Cerity Partners bought 4,289 Encompass Health shares in Q1 2026, an estimated $440K.
  • Encompass Health made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #1861 holding.
  • Cerity Partners first reported a position in Encompass Health in Q2 2023 and has held it in 10 quarters since.
  • Cerity Partners's Encompass Health position peaked at $6.29M in Q2 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.